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Pigs are an important host of influenza A viruses due to their ability to generate
reassortant viruses with pandemic potential. NS1 protein of influenza A viruses is a key
virulence factor and a major antagonist of innate immune responses. It is also involved in
enhancing viral mRNA translation and regulation of virus replication. Being a protein with
pleiotropic functions, NS1 has a variety of cellular interaction partners. Hence, studies
on swine influenza viruses (SIV) and identification of swine influenza NS1-interacting host
proteins is of great interest. Here, we constructed a recombinant SIV carrying a Strep-
tag in the NS1 protein and infected primary swine respiratory epithelial cells (SRECs)
with this virus. The Strep-tag sequence in the NS1 protein enabled us to purify intact, the
NS1 protein and its interacting protein complex specifically. We identified cellular proteins
present in the purified complex by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) and generated a dataset of these proteins. 445 proteins were identified
by LC-MS/MS and among them 192 proteins were selected by setting up a threshold
based on MS parameters. The selected proteins were analyzed by bioinformatics and
were categorized as belonging to different functional groups including translation, RNA
processing, cytoskeleton, innate immunity, and apoptosis. Protein interaction networks
were derived using these data and the NS1 interactions with some of the specific
host factors were verified by immunoprecipitation. The novel proteins and the networks
revealed in our study will be the potential candidates for targeted study of the molecular
interaction of NS1 with host proteins, which will provide insights into the identification of
new therapeutic targets to control influenza infection and disease pathogenesis.
Keywords: swine influenza virus, NS1 protein, swine respiratory epithelial cells, strep-tag, protein interaction
networks
INTRODUCTION
Influenza A viruses are globally important human and animal pathogens responsible for seasonal,
epidemic and periodically world-wide pandemic outbreaks. Among these viruses, swine influenza
viruses (SIV) are a common and an important cause of respiratory disease in pigs (Choi et al.,
2002; Palese, 2004). Pigs are an important host of influenza viruses which could harbor viruses
with a pandemic potential (Hinshaw et al., 1981; Kida et al., 1994; Alenzi, 2010), as they are known
to support the replication of both human and avian viruses. It has been shown experimentally
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that avian viruses of various HA subtypes, including those
containing non-human HA subtypes can infect and replicate
in pigs. Additionally, infection of pigs with a mixture of swine
virus and an avian virus, which are unable to replicate in pigs,
resulted in the generation of a reassortant that could replicate
in pigs (Kida et al., 1994). The 1957 and 1968 pandemics were
caused by reassortant viruses, believed to have been generated
by mixing of different strains of viruses after infection in pigs
(Kahn et al., 2014). The recent 2009 pandemic caused by a swine
origin H1N1 virus was also generated by reassortment in pigs
(Neumann et al., 2009). Hence, pigs serve as a mixing vessel for
the generation of novel viruses with pandemic potential. Several
cases of transmission of influenza from pigs to humans have also
been documented, which sometimes result in fatal outcomes for
humans (Hodder et al., 1977; Wells et al., 1991; Myers et al.,
2007; Jhung et al., 2013). Thus, there is a need for a better
understanding of SIV biology and the molecular mechanisms
involved during infection. However, knowledge on the molecular
basis of SIV infections is very limited and especially very little is
known about the host-virus protein interactions critical during
SIV infection.
Antiviral drugs form an important part of the arsenal for the
fight against influenza virus infections. Currently, two classes
of drugs are FDA-approved and available for treatment of
influenza virus infection: M2 ion channel inhibitors (amantadine,
rimantadine) and Neuraminidase inhibitors (NAIs) (oseltamivir,
zanamivir) (Davies et al., 1964; Gubareva et al., 2000; Hayden,
2001). However, a major problem is the frequent emergence
of viral resistance against these antiviral drugs. For example,
usage of amantadine and rimantadine, collectively called as
adamantanes, resulted in the rapid emergence of resistant
strains that it is no longer recommended for influenza antiviral
treatment (Bright et al., 2005). Resistance against oseltamivir,
zanamivir and newly developed NAIs peramivir and laninamivir
has also been reported (Hurt et al., 2009; Kamali and Holodniy,
2013; Orozovic et al., 2014; McKimm-Breschkin and Barrett,
2015). The error-prone nature of the viral RNA polymerase
makes it easy for the virus to gain resistance to drugs targeting
viral proteins (Watanabe et al., 2014). Therefore, nowadays
there is a growing emphasis for developing drugs targeting
host factors, where the possibility of the virus gaining drug-
resistance is minimal (Lou et al., 2014). Many antiviral drugs
targeting host factors are under different stages of development.
One among them is the sialidase drug DAS181, which removes
sialic acids on respiratory epithelial cells and prevents virus
attachment to the receptor (Belser et al., 2007). Resistance to
the drug was minimal and unstable upon extensive passaging
of influenza virus in the presence of DAS181 (Triana-Baltzer
et al., 2011). Other approaches using inhibitors to target cellular
proteases (Bottcher-Friebertshauser et al., 2010, 2011) and the
Raf/MEK/ERK signaling pathway (Droebner et al., 2011) have
also been demonstrated to be successful in inhibiting virus
infection. Treatment with immunomodulatory drugs targeting
the host immune system, such as COX-2 inhibitors and S1P
agonists have been found to alleviate tissue damage caused by
virus-induced cytokines and also suppress virus replication (Lee
et al., 2008, 2011; Marsolais et al., 2008). Additionally, many
other inhibitors that target cellular factors are known to affect
various stages of the influenza virus life cycle leading to reduced
virus replication (Muller et al., 2012).Thus, identification of
host factors affecting influenza virus infection is of paramount
importance for the basic understanding of virus life cycle and can
lead to novel antiviral therapy.
The NS1 protein of influenza A viruses is involved in
regulating splicing, export and translation of viral mRNA,
antagonizing host defenses and it fulfills these functions via
interaction with multiple cellular partners (Hale et al., 2008;
Marc, 2014). Although a variety of NS1 interaction partners
have been identified, there is still a great interest in discovering
novel interaction partners (Shapira et al., 2009; de Chassey
et al., 2013). During infection, the primary target for influenza
viruses are the respiratory epithelial cells in the trachea (Hers,
1966; Manicassamy et al., 2010). Therefore, studying SIV
replication by infecting primary swine respiratory epithelial cells
(SRECs) will resemble conditions close to natural infection.
Additionally, when compared to well-established cell lines,
analyzing protein interactions in primary cells may yield novel
NS1-interacting cellular partners. Thus, in this study, we
constructed a recombinant SIV carrying a Strep-tag in the NS1
protein in order to facilitate the isolation of an intact NS1-
interacting protein complex from infected SRECs. We identified
cellular proteins present in the purified complex by liquid
chromatography-tandem mass spectrometry (LC-MS/MS) and
generated a dataset of these proteins. We further analyzed the
dataset by bioinformatics and provided comprehensive networks
of host factors that interact with NS1. The interaction of
several specific cellular proteins with NS1 was validated by
immunoprecipitation.
MATERIALS AND METHODS
Cells and Viruses
New born porcine tracheal epithelial (NPTr) cells, which are
non-transformed and non-carcinoma SREC line capable of
supporting efficient replication of influenza viruses (Ferrari
et al., 2003; Delgado-Ortega et al., 2014; Thulasi Raman et al.,
2016), were maintained in minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS). Madin-
Darby canine kidney (MDCK) cells were also maintained in
MEM supplemented with 10% FBS. SRECs were isolated and
cultured as described elsewhere (Yamaya et al., 1992). Briefly,
trachea from healthy 6–8 week old pigs was obtained after
euthanization and washed in sterile phosphate buffered saline
(PBS). The trachea was transected longitudinally and the surface
epithelium was pulled off the submucosa using a glass microscope
slide. The epithelium was washed with Joklik’s MEM (JMEM)
(Sigma–Aldrich) containing glutamine (2 mM), Dithiothreitol
(0.5 mg/ml) (Sigma–Aldrich), Deoxyribonuclease (10 µg/ml)
(Sigma–Aldrich) and antibiotics for 3 h at 4◦C, changing the
media every 1 h. The tissue was then digested with protease
XIV (Sigma–Aldrich) in the above media for 18 h at 4◦C. After
18 h, the protease XIV was neutralized by adding FBS to a
final concentration of 20%. The media was filtered through a
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70 µm cell strainer and the cells were pelleted down and washed
with JMEM supplemented with 20% FBS. The cells were then
resuspended in Bronchial Epithelial Growth Medium (BEGM)
(Lonza Group Ltd.) with added growth factors from the bullet
kit (Lonza Group Ltd.) and then plated on an uncoated dish for
2–3 h and left in an incubator at 37◦C. Contaminating fibroblasts
attach to the plate, while epithelial cells are only lightly attached
and can be easily dislodged by gentle agitation. The floating cells
were once again washed in BEGM media and plated onto a Type
IV collagen (Sigma–Aldrich)-coated cell culture flask. Once the
cells reached 100% confluency, they were split on to Type IV
collagen-coated flasks and propagated further.
A/Sw/SK/18789/02 (H1N1) (SK02) virus was propagated in
11-day-old embryonated chicken eggs as described previously
(Shin et al., 2007a). Influenza virus titer was determined by plaque
assay on MDCK cells.
Antibodies and Reagents
Rabbit polyclonal anti-NS1 and NP antibodies were generated
in our laboratory as previously described (Shin et al., 2007b).
The other antibodies were purchased from different sources
as follows: Strep MAB-Classic antibody conjugated to
horseradish peroxidise (HRP) (IBA), Alkaline Phosphatase
(AP) – Conjugated anti-rabbit IgG (Jackson ImmunoResearch),
Mouse anti-Flag M2 antibody (Sigma–Aldrich), Rabbit anti-flag
DYKDDDDK tag antibody (Cell signaling technology), IRDye
680RD anti-Rabbit antibody (LI-COR), Mouse anti-human
cytokeratin (pan) (AbD Serotec), Goat F(ab’)2 Anti-Mouse
IgG1- FITC conjugate (Southern Biotech), mouse IgG1 negative
control antibody (AbD Serotec), Goat anti-Rabbit IgG secondary
antibody, Alexa Fluor 594 (Life Technologies).
Other reagents were purchased from the following sources
as follows: TransIT-LT1 (Mirus Bio LLC), Strep-Tactin
Sepharose 50% suspension (IBA), Strep-tag II peptide (IBA), D-
Desthiobiotin (IBA), Dynabeads protein G (Life Technologies),
Ni-NTA agarose resin (Qiagen).
Plasmid Construction and Generation of
Mutant Viruses
The DNA sequence corresponding to the Strep-tag (TGGTCACA
CCCACAGTTCGAAAAA) was introduced into pHW-SK-NS
(Masic et al., 2009) plasmid by overlapping PCR. Plasmid
pHW-SK-NS-Strep-replacement encodes SIV/SK-NS1 with
amino acids (AA) 77-84 replaced by the Strep-tag, while plasmid
pHW-SK-NS-Strep-insertion encodes SIV/SK-NS1 with the
Strep-tag inserted between AA 79 and 80.
The recombinant viruses encoding the Strep-tag NS1
were rescued using an eight-plasmid reverse genetics system
(Hoffmann et al., 2002). For rescue of the recombinant
viruses, plasmids pHW-SK-PB2, pHW-SK-PB1, pHW-SK-PA,
pHW-SK-HA, pHW-SK-NP, pHW-SK-NA, pHW-SK-M (Masic
et al., 2009) and one of either plasmids pHW-SK-NS-Strep-
replacement or pHW-SK-NS-Strep-insertion were transfected
onto co-cultured MDCK and 293T cells. The rescued viruses
designated SIV/SK-544 and SIV/SK-545 were propagated in
11-day-old embryonated eggs.
Western Blotting
A portion of the cell lysate (input), eluent or wash fractions
from the Strep-tactin sepharose pull-down experiment,
immunoprecipitation (IP) and samples for protein expression
kinetics were resolved by sodium dodecyl sulfate – 10%
polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting was performed as described elsewhere (Shin et al.,
2007b).
Real-time PCR
To measure IFNβ mRNA level in virus infected cells, RNA was
extracted from cells using the RNeasy mini kit. 500 ng of extracted
RNA was used for reverse transcription using oligo (dT)20 primer
and SuperScript III reverse transcriptase to generate cDNA. The
cDNA was then combined with the primer set and SYBR green
super mix. Quantitative real-time PCR (qPCR) reaction was
performed in an iCycler IQ5 multicolor real-time PCR detection
system (Bio-Rad, Hercules, CA) using the following primers:
porcine IFNβ forward, 5′-CCGAATTCGCTAACAAGTGCATC
CTCC-3′; porcine IFNβ reverse, 5′-GCGAAGCTTTCAGTTCC
GGAGGTAATC-3′; porcine RPL19 forward, 5′-AACTCCCGT
CAGCAGATCC-3′; porcine RPL19 reverse, 5′-AGTACCCTT
CCGCTTACCG-3′. RPL19 gene transcription was used for
normalization of IFNβ expression. Data are presented as relative
gene expression to that of mock infected cells using the formula
2−11Ct (Livak and Schmittgen, 2001). Real-time PCR was
conducted in triplicate for each sample and the mean value
was calculated. Final figures represent the results from three
independent experiments.
Purification of Strep-tagged NS1 Protein
Complex and Identification of Interacting
Proteins
SRECs’ were infected with SIV/SK-544 at an MOI of 2. At
16 h post infection (h.p.i.), cells were harvested in cell lysis
buffer (Cell Signaling Technology) with protease inhibitor
(Complete protease inhibitor cocktail tablets – Roche Diagnostics
Corporation). The lysate was sonicated and then clarified by
centrifugation at 16200 × g for 10 min at 4◦C. The Strep-
tactin sepharose resin (IBA) was washed three times with four
column volume (CV) of cell lysis buffer and then was added to
the clarified lysate and incubated at 4◦C overnight. Next, the
lysate-sepharose mixture was added to a polypropylene column
(Qiagen) and the sepharose was washed extensively with wash
buffer [100 mM Tris-Cl (pH 8.0), 150 mM NaCl, 1 mM EDTA].
The Strep-tag NS1 protein complex was then eluted from the
sepharose resin with 3 CV of elution buffer (wash buffer with
2.5 mM desthibiotin). Protease inhibitor cocktail was added to
the eluent to prevent degradation of the proteins and the proteins
present in the complex were identified by LC-MS/MS at the
University of Victoria-Genome BC Proteomics Centre.
Analysis of MS Data
The proteins identified by LC-MS/MS were enriched and
grouped into different functional categories using the functional
annotation tool of DAVID Bioinformatics Resources 6.7 (Jiao
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et al., 2012). The proteins from our NS1-interacting complex
were screened against the known NS1-host factor interactions
from VirHostNet (Virus–Host Network) 2.0, which is a public
knowledgebase dedicated to the management, analysis and
integration of virus–host interactions (Navratil et al., 2009;
Guirimand et al., 2015). Proteins annotated to be involved
in innate immunity were screened using the Gene Ontology
Analysis tool from InnateDB database (Lynn et al., 2008; Lynn
et al., 2010; Breuer et al., 2013).
Construction of Protein–Protein
Interaction Networks
Interaction networks of the proteins were generated through the
use of STRING database (version 10) (Jensen et al., 2009) and
Cytoscape software (version 3.2.0) (Shannon et al., 2003).
Transfection and IP
To examine NS1 interaction with the His-tagged and Flag-
tagged cellular proteins, 293T cells were seeded at a density
of 1 × 106 cells/well in six-well plates. One micro gram of
each plasmid encoding the protein of interest was transfected
using TransIT-LT1 as per the manufacturer’s recommendation.
The plasmids used for transfection include pcDNA-PR8-
NS1, pCMV-3 × Flag-hnRNP C, pCDNA4-HisMaxA-hnRNP
K, pCDNA4-HisMaxA-hnRNP U, pCDNA4-HisMaxA-hnRNP F,
pCDNA4-HisMaxA-hnRNP M, pCDNA4-HisMaxA-hnRNP R,
pcDNA4-HisMaxA-ILF2, pCDNA4-HisMaxA-ILF3, pCDNA4-
HisMaxC-DDX1. These cellular proteins were cloned into
pCMV-3 × Flag, pcDNA4-HisMaxA and pCDNA4-HisMaxC
plasmids, such that the Flag- or His-tag is fused at the N-terminal
of the expressed fusion protein.
For examining protein interaction between Flag-hnRNPC
and NS1 by IP, the cell lysate was collected in 1 ml Flag lysis
buffer (FLB) (50 mM Tris HCl, pH 7.4, with 150 mM NaCl,
1 mM EDTA, and 1% TRITON X-100). The cell lysate was
then sonicated and cleared of cellular debris by centrifugation.
Then, 1.5 µg mouse monoclonal anti-Flag M2 (Sigma–Aldrich)
antibody was added to the cell lysate and was incubated with
gentle rocking at 4◦C for 1 h and 15 min. Next, 35 µl of
Dynabeads Protein G (Life Technologies) was added to the lysate
and was further incubated for another 1 h and 15 min with gentle
rocking at 4◦C. The beads were then washed extensively with FLB
and the precipitated proteins were subjected to Western blotting
with appropriate antibodies.
For examining protein interaction between the His-tagged
cellular proteins and NS1, the cell lysate was collected in 1 × cell
lysis buffer (Cell Signaling Technology). The Ni-NTA agarose
resin (Qiagen) was washed in PBS and was incubated with the
lysate for 2 h at 4◦C. The beads were then washed three times
with FLB and three times with PBS. The precipitated proteins
were subjected to Western blotting with appropriate antibodies.
Statistical Analysis
The statistical significance of differences was calculated using
GraphPad Prism 6 (GraphPad Software, Inc., USA) with
parametric t-tests to obtain the P-value. Data are shown
as mean ± SD (standard deviation) of three independent
experiments. Significant differences between treatments and
controls are represented by an asterisk (P< 0.05) or two asterisks
(P < 0.01).
RESULTS
Construction and Characterization of
Strep-tagged NS1 Mutants
The NS1 protein is made of an RNA binding domain and an
effector domain joined by a flexible and highly variable linker
region (Qian et al., 1994; Bornholdt and Prasad, 2008). Our lab
had previously rescued mutant viruses having a TC-tag insertion
or a Strep-tag insertion in this variable region of NS1 (Li et al.,
2010; Lin et al., 2012). Since we were interested in studying
SIV NS1-interacting partners in its natural host, we rescued a
recombinant SIV possessing a Strep-tag sequence (WSHPQFEK)
in the linker region of NS1 protein in the background of SK02
virus. The presence of the Strep-tag sequence would enable the
purification of NS1 protein along with any associated proteins
from the infected cell lysate. Two mutant viruses were rescued:
SIV/SK-544 that encodes NS1 with a Strep-tag sequence replacing
AA 77 to 84 and SIV/SK-545 that encodes NS1 with a Strep-tag
sequence inserted between AA 79 and 80 (Figure 1A).
The replication potential of the recombinant viruses was
first assessed by comparing the plaque size and multiple cycle
growth kinetics to that of the wild type (WT) virus. Even though
plaque size of both mutants appear to be similar to WT virus
(Figure 1B), SIV/SK-545 was attenuated in multi-cycle growth
kinetics, while SIV/SK-544 displayed growth kinetics similar to
WT virus (Figure 1C).
We further characterized the phenotype of the mutant virus
to ensure that the introduction of the Strep-tag sequence did
not alter the function of the NS1 protein. Since SIV/SK-
544 mutant virus displayed similar plaque size and growth
kinetics as the WT virus, we focused on the SIV/SK-544
mutant for further characterization. Influenza NS1 has been
shown to predominantly localize in the nucleus of infected cells
(Greenspan et al., 1988; Newby et al., 2007) and its intracellular
distribution is vital for its multifunctional ability. Therefore,
we immunostained WT and SIV/SK-544 virus-infected cells
with antibodies specific for NS1 and observed the intracellular
localization of NS1 protein in the infected cells at 8 h.p.i. As
shown in Figure 1D, NS1 localized to the nucleus and nucleolus
in both SIV/SK-544 and WT virus-infected cells, revealing a
similar distribution pattern.
It is widely recognized that a major function of influenza virus
NS1 is to antagonize the host type-I interferon (IFN) response
(Hale et al., 2008; Marc, 2014; Ayllon and Garcia-Sastre, 2015).
Influenza viruses devoid of NS1 protein expression have been
instrumental in studying this response and have been observed
to be attenuated, inducing large amounts of IFN in infected
cells (Egorov et al., 1998; Garcia-Sastre et al., 1998; Haye et al.,
2009). Therefore, we compared the ability of SIV/SK-544 and
SIV/SK-WT viruses to inhibit the IFNβ response by measuring
IFNβ mRNA levels using quantitative real-time PCR (q-PCR) in
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FIGURE 1 | Characterization of recombinant Strep-tag NS1 viruses. (A) A schematic representation of the NS1 protein and the location of the Strep-tag
replacement and insertion within the NS1 protein sequence. (B) MDCK cells were infected with either the WT virus or the recombinant Strep-tag viruses. At 48 h.p.i.,
plaques were visualized by staining with coomassie blue. (C) MDCK cells were infected with either the WT virus or the recombinant Strep-tag viruses at an MOI of
0.001 in triplicates. Supernatant was collected every 24 h and the titer was determined by plaque assay on MDCK cells. A growth curve was plotted using the mean
titer values at each time point and the associated standard deviation is displayed as error bar. (D) MDCK cells were infected with either the WT virus or the mutant
SIV-SK/544 virus at an MOI of 2. At 8 h.p.i., the cells were fixed, permeabilized and stained with rabbit anti-NS1 serum followed by Alexa Fluor 594-conjugated
anti-rabbit antibody (red) and mounted with a mounting media containing DAPI stain (blue). A representative image of multiple fields of view is shown. (E) NPTr cells
were infected with SIV/SK-WT, SIV/SK-544, or PR8 del NS1 virus at an MOI of 1. At 12 h.p.i., the cell lysate was collected and RNA was extracted. The RNA was
reverse transcribed and the cDNA was then used in qPCR experiments to determine IFNβ mRNA expression. Real-time PCR was conducted in triplicate for each
sample and the mean value was calculated. Final figures represent the results from three independent experiments and the associated standard deviation is
displayed as an error bar. Significant differences between treatments and controls are represented by an asterisk (p < 0.05) or two asterisks (p < 0.01). Samples
with p < 0.05 were considered statistically significant, while p > 0.05 was considered not significant (ns). The expression of viral proteins present in the infected cell
lysate was detected by Western blotting.
infected cells. A PR8 virus lacking the NS1 gene (del NS1 virus)
was used as a positive control for IFNβ expression. As shown
in Figure 1E, the IFNβ mRNA expression levels were reduced
by 14000-fold and 11000-fold in SIV/SK-WT and SIV/SK-544
infected cells, when compared to IFNβ mRNA expression in
del NS1 virus infected cells. Western blotting analysis of viral
NP and NS1 proteins indicated that SIV/SK-WT and SIV/SK-
544 expressed similar levels of NP and NS1 at 12 h.p.i. (lane
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1 and 2), while only NP protein expression was observed in
del NS1 virus infected cell lysate (lane 3). These results show
that introduction of the Strep-tag sequence does not affect NS1
expression, localization and function of the recombinant virus.
Therefore, we used SIV/SK-544 virus for further studies to isolate
the intact NS1-interacting protein complex from infected cells.
Identification of Cellular Interaction
Partners of NS1 Protein from Infected
Primary SRECs
To identify the interactors in a more relevant natural infection
setting, primary SRECs were isolated from the trachea of healthy
6–8 week old pigs and cultured on collagen-coated culture
flasks. The cultured primary cells displayed typical cobble-stone
morphology (data not shown) and almost all of the cultured
cells stained positive for the epithelial cell marker cytokeratin
(Bateman et al., 2013) (Figure 2A), confirming their epithelial
nature.
To ensure that the virus can replicate efficiently in primary
SRECs, we infected SRECs with the WT and mutant viruses at an
MOI of 1 and collected the cell lysate at different time points. The
cell lysate was then subjected to Western blotting with antibodies
against NS1, NP and Strep-tag. The protein expression kinetics
was found to be similar for both WT virus and SIV/SK-544 virus
in infected SRECs (Figure 2B). Moreover, while the NS1 antibody
detected both WT NS1 and Strep-tagged NS1, only Strep-tagged
NS1 was detected by the antibody against Strep-tag.
We next tested the accessibility of the Strep-tag to Strep-
tactin, a derivative of streptavidin which binds to the Strep-tag
specifically with high affinity (Schmidt and Skerra, 2007). SRECs
were infected with either WT or SIV/SK-544 virus. At 16 h.p.i.,
the cell lysate was prepared and subjected to a pull-down assay
with Strep-tactin resin. We chose the 16 h time point for cell
lysate collection as the NS1 protein expression in SIV/SK-544
SRECs was robust at this time point, when compared to 8 h.p.i.
(Figure 2B). To identify viral and cellular proteins that may bind
non-specifically to the Strep-tag alone, purified Strep-tag peptide
was added to the WT virus-infected lysate and incubated along
with the Strep-tactin resin in the pull-down experiment. The
presence of NS1 in the eluent, flow-through and wash fractions
was determined by Western blotting (Figure 2C). Only NS1 from
SIV/SK-544-infected cells could be pulled down efficiently (lane
11), while the WT NS1 protein did not bind to the resin and
was lost during the washes (lanes 4 and 5). The eluent from
WT virus-infected and SIV/SK-544-infected cell lysate were also
analyzed by SDS-PAGE and silver staining (Figure 2D). The band
corresponding to NS1 in SIV/SK-544 eluent was visible in the
silver-stained gel and proteins interacting with NS1 were also co-
eluted (lane 2). In contrast, no visible bands were observed in the
eluent from WT virus-infected sample (lane 3).
The proteins present in the NS1 pull-down complex from
SIV/SK-544- and WT virus-infected cells were then identified
by LC-MS/MS. As a result, only five proteins were identified
in the SIV/SK-WT eluent, whereas 445 proteins were identified
in the eluent from SIV/SK-544-infected cells. While no viral
proteins were identified in the SIV/SK-WT eluent, viral proteins
PB2, PB1, PA, HA, NP, and M1 were identified in SIV/SK-
544 eluent. The proteins present in the complex were identified
using a software package called Mascot from Matrix Science1,
which compares the observed mass spectra data to a database
of known proteins to determine the most likely matches. As
the availability of swine protein sequences in the database is
limited, the LC-MS/MS data was used to search against all the
available mammalian sequences for protein identification. For
each protein match, Mascot calculates an overall protein score,
which reflects the combined score of all the observed mass spectra
that can be matched to amino acid sequences within that protein.
Therefore, a higher score indicates a more confident match.
To be more stringent in specificity, we set a threshold to be a
MASCOT protein score of 150 and above. Additionally, we also
excluded those proteins identified with a single peptide match
by LC-MS/MS and those proteins identified to be present in the
SIV/SK-WT eluent. By setting up this threshold and exclusion, we
were able to restrict our analysis to the proteins with the highest
confidence scores and thereby ended up with 192 proteins (43%
of the total number, Supplementary Table S1) for further analysis.
Bioinformatics Analysis of the Protein
Dataset
VirHostNet 2.0 database provides a high-confidence resource
of manually curated interactions defined for a wide range of
viral species including influenza virus. We screened the influenza
virus–host interaction database in VirHostNet 2.0 against the
192 top scoring proteins identified in our MS analysis and
found that 92 out of the 192 proteins have been documented
in the VirHostNet 2.0 database as NS1-interacting partners
(Supplementary Table S1). This analysis gave further proof
that the proteins identified in our study are valid NS1 protein
interaction partners.
NS1 exerts its multifunctional nature primarily by interacting
with host proteins. Therefore, categorizing and grouping the
proteins identified by LC-MS/MS on the basis of their molecular
functions in the host will reveal potential pathways that
might be affected by NS1 expression during infection. Gene
Ontology enrichment analysis was performed using the DAVID
bioinformatics resources (Jiao et al., 2012). A number of
important terms were identified to be enriched including protein
translation, RNA processing and splicing, microtubules and
cytoskeleton and apoptosis (Table 1). These are known to
be important host functions regulated during influenza virus
infection and are discussed below.
There are several reports supporting a role for NS1 in
the selective translation of viral mRNAs over cellular mRNAs
(Garfinkel and Katze, 1993; de la Luna et al., 1995; Park and
Katze, 1995; Marc et al., 2013). It is widely believed that NS1
interacts with the 5′UTR of viral mRNA, eIF4GI, and PABP1
and facilitates recruitment of the 40S ribosomal subunit bound
to eIF3, thereby enhancing selective translation of viral mRNA
(Hale et al., 2008; Marc, 2014). NS1 protein has also been shown
to interact with hStaufen (STAU1) (Falcon et al., 1999), which is
known to contribute toward microtubular transport of cellular
1www.matrixscience.com
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FIGURE 2 | Protein expression kinetics and NS1 protein Strep-tactin pull-down from WT and SIV/SK-544 virus infected SRECs. (A) SRECs were stained
with an antibody against the epithelial cell marker cytokeratin and the purity of the cells was analyzed using a fluorescence-activated cell sorter machine. (B) SRECs
were infected with WT or SIV/SK-544 virus at an MOI of 1. Cell lysate collected at the indicated time points were subjected to Western blotting with antibodies
specific for NP, NS1, and Strep-tag. (C) SRECs were infected with either the WT virus or SIV/SK-544 virus at an MOI of 2. At 16 h.p.i., cell lysate was collected and
subjected to a pull-down assay with Strep-tactin sepharose. The Flow through (FT), Wash fractions (W1, W2) and the Eluent were collected and subjected to
Western blotting with antibody against NS1. (D) The eluent from the SIV/SK-544 and SIV/SK-WT lysate were run on a SDS-PAGE gel and the proteins present in the
eluent were visualized by silver staining.
mRNAs to polysomes. This interaction is thought to enhance
the selective translation of viral mRNA by NS1. In line with
these observations, PABP1 and STAU1 were identified in the
NS1-interacting complex in our study (Supplementary Table S1)
along with several other cellular proteins involved in translation
(Supplementary Table S2).
Once the vRNP is in the cytoplasm, it is transported into the
nucleus by the nuclear import machinery in association with
viral proteins (Wang et al., 1997; Cros et al., 2005). Once in
the nucleus, genomic replication, transcription and pre-mRNA
processing takes place. Influenza viruses are unique among RNA
viruses in that the whole replication cycle takes place inside the
nucleus and not in the cytoplasm (Herz et al., 1981), as the virus
needs the host splicing machinery to splice the NS1 and M1
mRNA into smaller NS2 and M2 mRNA, respectively, (Lamb and
Lai, 1980; Lamb et al., 1981). NS1 protein affects several functions
in RNA processing. Influenza NS1 is reported to increase the
splicing of viral M mRNA but does not appear to affect the
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TABLE 1 | Table showing the DAVID functional annotation summary of the
NS1-interacting protein dataset.
David functional annotation summary
GO term No. of genes involved P-value
Translation 59 4.80E–56
RNA processing 41 2.60E–21
RNA splicing 24 7.40E–13
Microtubule & Cytoskeleton 20 1.60E–04
Regulation of apoptosis 13 1.20E–01
PDZ 3 3.80E–01
The number of genes involved in each of the enriched Gene Ontology (GO) term
and the P-values corresponding to each term is listed.
splicing of its own mRNA (Robb et al., 2010; Robb and Fodor,
2012). Contrary to this enhancing effect, influenza NS1 protein is
known to inhibit cellular pre-mRNA splicing by associating with
spliceosomes and U6 snRNA, contributing to host’s shut-off (Lu
et al., 1994). Moreover, influenza NS1 protein is also proposed
to have a function in nuclear export of viral mRNAs and has been
shown to interact with several proteins involved in nuclear export
including NXF1 (Satterly et al., 2007). Its binding to cellular
protein CPSF inhibits polyadenylation of host pre-mRNAs and
prevents their nuclear export (Nemeroff et al., 1998). Various
hnRNP proteins and the NXF1 interacting protein THOC4 are
also involved in cellular mRNA splicing and processing (Dreyfuss
et al., 1993; Masuda et al., 2005; Hautbergue et al., 2008). Thus,
many of the proteins involved in RNA processing and splicing
were identified in our study. Among the NS1-interacting host
proteins, 41 proteins and 24 proteins were annotated by DAVID
to be involved in RNA processing and RNA splicing, respectively,
which includes CPSF1, CPSF2, 8 out of the 20 known hnRNP
proteins and THOC4 (Supplementary Table S2).
Apoptosis is an important innate immune mechanism to
maintain homeostasis in the host and is a major pathway
regulated during influenza infection (Takizawa et al., 1993;
Hinshaw et al., 1994). Influenza virus has been documented
to modulate apoptosis to favor efficient virus replication by
interacting with several host proteins through its viral proteins
including NS1 (Herold et al., 2012; Iwai et al., 2013). A recent
study showed that NS1 interaction with β-tubulin disrupts the
cellular microtubule network and thereby commits the cell to
apoptosis (Han et al., 2012). NS1 interaction with the p85
regulatory subunit and CRK/CRKL prevents premature cell-
death and facilitates enhanced virus replication (Shin et al., 2007c;
Ehrhardt and Ludwig, 2009; Hrincius et al., 2010). Additionally,
the microtubule and cytoskeleton network also contributes to
trafficking of vRNPs from the cytoplasm to the cell periphery
for assembly and budding of the virus (Amorim et al., 2011).
Twenty and 13 proteins from our dataset were annotated by
DAVID to belong to the microtubule and cytoskeleton network
and apoptosis pathway, respectively, (Supplementary Table S2).
Thus, the functions enriched by DAVID gene ontology analysis
are relevant to the functions regulated by NS1 during virus
infection and the NS1-interacting host proteins identified in our
study could have important role in regulating these functions.
Generation of interaction networks representing the proteins
involved in RNA processing, apoptosis, and microtubule and
cytoskeleton emphasized the close relationship between these
factors to form a functional protein complex (Figures 3 and
4A,B, respectively).
NS1 is a known antagonist of innate immune response
(Hale et al., 2008; Marc, 2014; Ayllon and Garcia-Sastre,
2015). Therefore, we analyzed the protein dataset for factors
involved in innate immunity. InnateDB is a manually curated
knowledgebase of the genes, proteins, interactions, and signaling
responses in mammalian innate immunity (Breuer et al., 2013).
Thus, we screened our dataset against the genes present in
the innateDB database, which have been annotated to have
a role in innate immune response. Eighteen proteins from
our dataset were identified which belonged to this database
(Supplementary Table S2). Several proteins listed in the table
are well known interactors of NS1. Our laboratory and others
reported that DHX9 and DDX21 interact with NS1 and regulate
virus replication (Lin et al., 2012; Chen et al., 2014). Very recently,
we also showed that DDX3 interacts with NS1 and plays an
antiviral role through regulation of stress granule formation
(Thulasi Raman et al., 2016). CRKL was reported to interact with
NS1 and induce enhanced PI3K signaling (Ylosmaki et al., 2015).
Other proteins such as FXR1 and ILF3 have known function
during influenza infection, but have not been reported to interact
with NS1 (Wang et al., 2009; Zhou et al., 2014). Hence, NS1 being
an antagonist of innate immune responses, it might be interesting
to study the interaction of these cellular proteins with NS1 and
their function. A protein interaction network of these host factors
revealed strong associations between these proteins (Figure 5).
Validation of Specific Proteins in the NS1
Host Protein Interactors Dataset
hnRNP proteins are abundant nuclear proteins known to be
bound to pre-mRNAs in the nucleus (Dreyfuss et al., 1993) and
they function in splicing and nuclear export of pre-mRNA in
eukaryotic cells (Dreyfuss et al., 1993; Chou et al., 1999), which
are also functions shared by influenza virus premRNAs (York
and Fodor, 2013). Multiple hnRNP proteins have been found to
interact with viral proteins including hnRNP A2/B1 (Wang et al.,
2014), hnRNP M and H1 (Jorba et al., 2008), and hnRNP A1
(Mayer et al., 2007). ILF3 is a dsRNA binding protein and has
been shown to affect influenza virus replication by interacting
with NP (Saunders and Barber, 2003; Wang et al., 2009; Wen
et al., 2014). ILF2 is a binding partner of ILF3 and the ILF2-ILF3
heterodimer is involved in the post-transcriptional regulation of
many genes in vertebrates (Jayachandran et al., 2016). Therefore,
we tested the ability of several hnRNP proteins, ILF2, ILF3, and
DDX1 present in our dataset to interact with NS1 protein. In
order to test interaction between hnRNP C and NS1, plasmids
encoding Flag-tagged hnRNP C and influenza virus NS1 proteins
were co-transfected in 293T cells and the cell lysate was subjected
to IP using anti-flag antibody (Figure 6A) (Note that Flag beads
bind non-specifically to NP. Therefore, IP was not performed
in infected cells to avoid non-specific pull-down of NS1 due to
NP binding). 293T cells were transfected with plasmids encoding
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FIGURE 3 | Interaction network of proteins involved in RNA processing. The proteins classified as related to RNA processing machinery were analyzed by
STRING database and an interaction network was generated using Cytoscape. The edges connecting NS1 and known NS1-interacting host proteins are
represented by dashed lines and the NS1-interacting host protein nodes are highlighted by an octagon shaped border. Nodes represent the proteins in the network.
Edges represent the interaction connecting two nodes.
FIGURE 4 | Interaction network of proteins involved in Apoptosis and Cytoskeleton network. The proteins classified as belonging to the (A) apoptosis
pathway and (B) cytoskeleton network were analyzed by STRING database and an interaction network was generated using Cytoscape. The edges connecting NS1
and known NS1-interacting host proteins are represented by dashed lines and the NS1-interacting host protein nodes are highlighted by an octagon shaped border.
Nodes represent the proteins in the network. Edges represent the interaction connecting the two nodes.
His-tagged hnRNP proteins hnRNP F, K, M, R, U, and ILF2, ILF3,
and DDX1. The cells were then infected with SIV/SK-WT virus
and the cell lysate was subjected to IP using Ni-NTA agarose
(Figures 6B–D). The His- or Flag-tagged proteins and the NS1
protein present in the pull-down (P/D) were detected by Western
blotting. While hnRNPs C, K, U, ILF3, and DDX1 co-precipitated
NS1 (lower panels, lane 2 of Figures 6A–C, lane 6 of Figure 6C,
lane 4 of Figure 6B), hnRNP F, M, R, and ILF2 failed to co-
precipitate NS1 (lower panels, lanes 2, 4, 6 of Figure 6D and lane
4 of Figure 6C).
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FIGURE 5 | Interaction network of innate immunity related proteins. The proteins classified as belonging to innate immune response pathway were analyzed
by STRING database and an interaction network was generated using Cytoscape. The edges connecting NS1 and known NS1-interacting host proteins are
represented by dashed lines and the NS1-interacting host protein nodes are highlighted by an octagon shaped border. Nodes represent the proteins in the network.
Edges represent the interaction connecting the two nodes.
DISCUSSION
The NS1 protein is a major virulence factor of influenza A
viruses and exerts its multifunctional nature by interacting
with several cellular proteins (Hale et al., 2008; Marc, 2014).
Several studies have used varied strategies to identify the NS1-
interacting partners, which have advantages as well as limitations.
While, yeast two-hybrid assay system is useful in studying
dual interactions and has been used to identify novel host
interaction partners of NS1 protein (Shapira et al., 2009; de
Chassey et al., 2013), they do not represent interactions that
occur in the context of virus infection or in protein complexes.
Some studies identified cellular interaction partners of NS1 by
exogenous expression of the viral protein in established cell
lines and then co-precipitating the interacting cellular proteins
by immunoprecipitation (Pichlmair et al., 2012; Watanabe
et al., 2014). While this approach is useful in studying virus–
host protein interactions that occur in a protein complex,
it does not represent interactions that arise in the context
of virus infection. Recently, a novel approach was used to
rescue recombinant influenza viruses expressing epitope-tagged
NS1 protein (Tawaratsumida et al., 2014). Even though, this
approach resulted in the identification of physiologically relevant
interactions that occur in the infected cells, both NS1 and NS2
proteins were tagged, which led to the inability to distinguish
between proteins that interact specifically with either NS1 or NS2.
In our study, a strategy was devised to introduce a Strep-
tag sequence specifically in the NS1 protein in order to analyze
protein interactions of NS1 occurring during virus replication.
The flexible and variable nature of the linker region between the
RNA-binding domain (RD) and effector domain (ED) of NS1
has been demonstrated in several studies. Large scale sequence
analysis of the NS1 sequence from various influenza A virus
strains showed that the amino acid residues D74-L77 and K79-
R83 in the linker region between the RD and ED of NS1 is highly
variable (Darapaneni et al., 2009). Moreover, an X-ray structure
study on NS1 observed the region corresponding to residues
75–79 as not well-defined, which shows that the linker region
is highly flexible in nature (Bornholdt and Prasad, 2008). This
region is amenable for modifications, which was demonstrated
by previous studies in our laboratory involving tetracysteine
(TC) tag and Strep-tag insertions in NS1 (Li et al., 2010; Lin
et al., 2012). Taking advantage of this knowledge, an eight amino
acid Strep-tag sequence was inserted in the SK02 NS1 linker
region and a recombinant SK02 virus encoding a Strep-tag NS1
(SIV/SK-544) with growth properties, protein expression kinetics
and anti-interferon function similar to that of WT virus was
successfully rescued (Figure 1). This resulted in the introduction
Frontiers in Microbiology | www.frontiersin.org 10 May 2016 | Volume 7 | Article 654
fmicb-07-00654 May 2, 2016 Time: 11:19 # 11
Thulasi Raman and Zhou NS1-Interacting Partners
FIGURE 6 | NS1 interaction with specific cellular proteins. (A) pcDNA-NS1 was co-transfected with plasmid encoding Flag-hnRNPC or Flag-vector in 293T
cells. At 48 h.p. transfection, cell lysate was collected and subjected to IP with anti-Flag antibody. Precipitated proteins were subjected to Western blotting with
antibodies against Flag-tag and NS1. (B–D) Plasmid encoding His-tagged hnRNPs or DDX1 was transfected in 293T cells. At 36 h.p. transfection, cells were
infected with SIV/SK-WT at an MOI of 1. At 12 h.p.i., cell lysate was collected and subjected to IP with Ni-NTA agarose resin. Precipitated proteins were subjected to
Western blotting with antibodies against His-tag and NS1. I/P = input. P/D = Pull-down.
of the Strep-tag sequence specifically in NS1 without affecting the
packaging signals or splicing of NS gene segment.
The Strep-tag sequence is engineered to bind with high affinity
and reversibly to strep-tactin, enabling the isolation of intact
protein complexes (Schmidt and Skerra, 2007). While previous
studies utilized well-established cell lines for virus–host protein
interaction studies, we performed our studies on primary cells
isolated from the trachea of healthy pigs to resemble natural
infection conditions. Thus, SRECs were infected with SIV/SK-
544 and the presence of Strep-tag sequence in the NS1 protein
facilitated the purification of an intact NS1-interacting protein
complex (Figures 2C,D). The host and viral proteins present in
the purified NS1–host protein complex were identified by LC-
MS/MS. Since NS1 interaction with cellular proteins is critical
for its multifunctional nature, the host proteins present in the
purified complex could in turn provide an understanding of the
pathways regulated by NS1 during infection. Therefore, DAVID
bioinformatics resources was used to group proteins in the
dataset. Several host functions important for virus replication
were identified by this analysis (Table 1) and protein-interaction
networks were derived using STRING database. Cytoscape
helped visualize the interactions among the cellular proteins and
NS1 in each group (Figures 3–5). Thus, bioinformatics analysis
of the protein dataset provided an insight into the different
host functions that may be regulated through NS1 during virus
infection.
We validated our study by confirming the interaction between
some of the hnRNP proteins, DDX1 and ILF3. Our IP studies
established that hnRNP C, hnRNP K, hnRNP U, ILF3, and
DDX1 interacted with the NS1 protein (Figures 6A–C). hnRNP
K protein is known to interact with the cellular protein NS1-
binding protein (NS1-BP) and plays a major role in M1 mRNA
splicing by binding directly to M1 mRNA (Tsai et al., 2013).
hnRNP U and hnRNP C proteins are differentially expressed in
H3N2 virus-infected cells when compared to uninfected cells.
Additionally, hnRNP C protein translocates from the nucleus
to the cytoplasm and colocalizes with NS1 protein in infected
cells (Wu et al., 2013). ILF3 is a component of stress granules
and inhibits influenza virus replication through direct interaction
with viral NP and PKR (Wang et al., 2009; Wen et al., 2014).
DDX1 in complex with other RNA helicases DDX21 and DHX36
acts as a viral sensor to induce type I IFN expression (Zhang
et al., 2011). Thus interaction of these cellular proteins with NS1
could have significant implications for influenza virus infection.
While we were able to confirm interaction of NS1 with the
above mentioned proteins, NS1 did not interact with hnRNPs
F, M, and R and ILF2 (Figures 6C,D). It is possible that, these
proteins form a part of the NS1-interacting complex through its
interaction with other NS1-interacting cellular proteins present
in the complex. Alternatively, they may also interact with other
viral proteins that were identified by LC-MS/MS to be present in
the NS1-interacting complex.
Many of the previously known NS1-interacting proteins
such as PABP1, DHX9, DDX21, and CRKL were identified in
this study. Additionally, 92 out of the 192 proteins analyzed
in our dataset were listed as known NS1 interactors in the
Frontiers in Microbiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 654
fmicb-07-00654 May 2, 2016 Time: 11:19 # 12
Thulasi Raman and Zhou NS1-Interacting Partners
VirHostNet 2.0 database, which increased the confidence in
our dataset (Supplementary Table S1). Meanwhile, some of the
well-known NS1 binding partners such as p85β and CPSF30
were not identified in the NS1-interacting protein complex. The
absence of these well-known NS1-interacting partners could
be due to the inherent limitations of protein identification by
mass spectrometry, such as missed and non-specific cleavage
of proteins during trypsin treatment and availability of spectral
information of proteins in the database (Lubec and Afjehi-Sadat,
2007). Additionally, polymorphisms in the protein sequence of
the NS1 used in this study may also be responsible for the absence
of the well-known NS1 binding partners. Examples of these
polymorphisms playing a role in binding to different cellular
partners have been demonstrated in other studies (Shapira et al.,
2009; de Chassey et al., 2013).
It is well documented that significant polymorphisms exist
in the NS1 sequences among various strains (Marc, 2014).
SK02 virus is a wholly avian virus isolated from pigs (Karasin
et al., 2004) and because of this the NS1 protein has some
unique sequences and motifs. NS1 protein of influenza A
viruses are known to have a PDZ-binding domain (PBM) at
the last four amino acid residues (Obenauer et al., 2006).
As the name suggests, PBMs confer binding to proteins
containing a characteristic structure called the PDZ domain. PDZ
domain-containing proteins act as scaffolds to assemble protein
complexes and function in cell signaling and cell polarity (Harris
and Lim, 2001; Nourry et al., 2003). Human influenza A virus
isolates contain a PBM with varied sequences depending on the
strain and NS1 from H5N1 avian influenza A virus isolates from
human infections generally have a PBM with the sequence ESEV
(Golebiewski et al., 2011). Some studies have shown that avian
NS1 with ESEV PBM can bind PDZ proteins Scribble, Dlg1,
MAGI-1, MAGI-2, MAGI-3, and possess an indirect association
with Lin7C (Liu et al., 2010; Golebiewski et al., 2011; Thomas
et al., 2011). The SK02 virus used in our study for infections has
the same avian signature ESEV PBM (AA 227–230) in the NS1
protein. Therefore, we were interested in finding out, whether any
of the above mentioned proteins have been identified in our pull-
down complex. Consistent with the literature, Dlg1 and Lin7C
were indeed present in our dataset (Supplementary Table S2).
This interaction has been shown to decrease tight junction
integrity of the epithelial cells and benefit virus replication (Liu
et al., 2010; Golebiewski et al., 2011; Thomas et al., 2011).
It has been observed that, most avian influenza A viruses have
a class II SH3 domain in the NS1 protein with the sequence
PPLPPK at AA 212-217, while this motif is rarely seen in human
influenza viruses (Heikkinen et al., 2008). NS1 proteins with this
sequence have been shown to bind to cellular adaptor protein
CRK/CRKL, while the NS1 proteins of human influenza A viruses
do not bind to this sequence (Heikkinen et al., 2008; Hrincius
et al., 2010). Consequently, NS1-CRK/CRKL interaction inhibits
virus induced activation of JNK-ATF2 pathway, which in turn
prevents premature cell death and thereby facilitates enhanced
virus replication (Hrincius et al., 2010). The NS1 protein of
SK02 also possesses a class II SH3 binding motif and CRK/CRKL
protein was identified in our pull-down complex (Supplementary
Table S1). All these unique interactions could have a significant
effect on the pathogenesis of the virus at the cellular level.
Taken together, the cellular proteins identified in this
complex could provide an insight into the different pathways
important for influenza infection through interaction with NS1
protein. Validation and characterization of these interactions
will provide a deeper understanding of the virus–host interplay,
the co-evolution mechanisms that molded the host–pathogen
relationship and will help in the identification of new therapeutic
targets to control influenza infection and disease pathogenesis.
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